Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Dianabol Overview, Dosing & Safety | Peptide Database

Dianabol (Dbol) Oral Anabolic Steroid | Classic Mass Builder Community Research Join others researching Dianabol — share findings, ask questions, and learn from real experiences Dianabol (methandrostenolone) is the original oral anabolic steroid, developed in

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Dianabol (Dbol)

Oral Anabolic Steroid | Classic Mass Builder

Community Research

Join others researching Dianabol — share findings, ask questions, and learn from real experiences

Dianabol (methandrostenolone) is the original oral anabolic steroid, developed in the late 1950s by Dr. John Ziegler in collaboration with Ciba Pharmaceuticals for the US Olympic team. It was briefly FDA-approved for medical use but was discontinued from the US market in the 1980s due to abuse potential and side effect concerns. Despite its removal from pharmaceutical production, Dianabol remains one of the most widely used performance-enhancing compounds in the world due to its rapid and dramatic effects on muscle mass and strength. It is a 17-alpha-alkylated derivative of testosterone with an added C1-C2 double bond, which shifts its profile toward more anabolic and less androgenic activity compared to testosterone. Dianabol aromatizes heavily to methylestradiol, causing significant water retention and estrogenic side effects. Its short half-life of 4-6 hours necessitates split dosing throughout the day for stable blood levels. It is most commonly used as a 4-6 week kickstart to injectable cycles, providing rapid size and strength gains while longer-acting compounds like testosterone enanthate or cypionate reach steady-state levels.

Dianabol exerts its effects primarily through binding to the androgen receptor (AR), promoting nitrogen retention, protein synthesis, and glycogenolysis in skeletal muscle tissue. Its 17-alpha-alkylated structure allows it to survive first-pass hepatic metabolism, enabling oral bioavailability but placing significant stress on the liver. Dianabol has a notably high anabolic-to-androgenic ratio compared to testosterone, meaning it preferentially drives muscle-building pathways over androgenic effects such as body hair growth and prostate stimulation. It also strongly promotes intramuscular water and glycogen storage, which contributes to the rapid weight gains and fullness characteristic of its use. Dianabol aromatizes readily via the aromatase enzyme, converting to methylestradiol (a potent estrogen), which drives much of the water retention, blood pressure elevation, and gynecomastia risk associated with the compound. This heavy aromatization typically necessitates concurrent use of an aromatase inhibitor at moderate to high doses.

Molecular Data

Research Indications

Dianabol is primarily used for rapid increases in bodyweight and muscle mass. Users typically gain 10-20 lbs during a 4-6 week cycle, though a significant portion is water and glycogen retention that will subside after discontinuation.

Dramatic increases in strength across all major compound lifts, often noticeable within the first week of use. Strength gains are among the most rapid of any oral anabolic steroid.

Most commonly used during the first 4-6 weeks of a longer injectable cycle to provide immediate results while testosterone or other long-ester injectables reach peak blood levels.

Dianabol was originally prescribed for treatment of muscle wasting, osteoporosis, and recovery from burns or surgery. These medical applications have been entirely replaced by safer compounds.

Previously used for bone density support in post-menopausal women and elderly patients. Discontinued due to virilization risks and availability of better-tolerated alternatives.

Dosing Protocols

Dianabol is administered orally as tablets or capsules, typically in 10 mg, 25 mg, or 50 mg dosages. Its 17-alpha-alkylated structure allows oral bioavailability but causes hepatic stress that limits cycle length. The short 4-6 hour half-life means doses should be split throughout the day for more stable blood levels, though some users take the full dose pre-workout for an acute performance boost.

Beginner Kickstart

20-30 mg/day

Split into 2-3 doses throughout the day

Oral

Intermediate Kickstart

30-50 mg/day

Pre-Workout Timing

20-50 mg (full daily dose)

Single dose 60-90 minutes pre-workout

Protocol Variations

Multiple approaches exist - compare before choosing

Different sources recommend different protocols for this peptide. Review each approach and consider your goals, tolerance, and experience level before choosing.

Classic Dbol Kickstart

Source: Standard Bodybuilding Protocol

"Use Dianabol for the first 4-6 weeks of a testosterone cycle to provide immediate mass and strength gains while the injectable base compound reaches steady-state blood levels."

The most common and time-tested approach to Dianabol use. Run alongside a testosterone base (typically 400-500 mg/week of testosterone enanthate or cypionate) for the opening weeks of a bulking cycle. The rapid weight and strength gains from Dianabol bridge the gap before testosterone fully saturates, providing motivation and visible progress from day one.

Key Points

Always run with a testosterone base - never Dianabol solo

4 weeks is the conservative standard; 6 weeks is the upper limit for liver safety

Aromatase inhibitor (Anastrozole 0.5 mg EOD or Arimidex equivalent) is typically necessary

Liver support with TUDCA (500 mg/day) and NAC (600-1200 mg/day) is strongly recommended

Expect 10-20 lbs of weight gain, with 5-10 lbs retained after water loss post-cycle

Dosing Schedule

Low-Dose Dbol with TRT

Source: Modern Minimalist Approach

"Use a low dose of Dianabol as a mild oral addition to TRT for enhanced well-being, strength, and fullness without extreme side effects."

A more conservative approach gaining popularity in the TRT community. Low-dose Dianabol (10-20 mg/day) added to a standard TRT protocol provides noticeable improvements in strength, mood, and muscle fullness without the dramatic water retention and liver stress of higher doses. Some practitioners use this intermittently (4 weeks on, 8 weeks off) as a periodic boost.

Lower dose (10-20 mg/day) significantly reduces side effect burden

Less water retention and blood pressure impact than standard doses

Liver stress is reduced but not eliminated - monitoring is still required

May not require an aromatase inhibitor at 10-15 mg/day for some individuals

Used intermittently rather than as part of a blast cycle

Interactions

What to Expect

Side Effects & Safety

Common Side Effects

Significant water retention and bloating (estrogen-mediated)

Elevated blood pressure from fluid retention and increased red blood cell mass

Liver stress with elevated ALT/AST enzymes (dose and duration dependent)

Back pumps (painful lower back cramping during exercise)

Increased appetite

Oily skin and acne

Suppression of endogenous testosterone production (HPTA suppression)

Mild mood changes (increased aggression, irritability, or euphoria)

Stop Signs - Discontinue if:

Yellowing of skin or eyes (jaundice - indicates serious liver distress)

Severe persistent upper right abdominal pain (hepatic distress)

Dark brown or tea-colored urine (potential liver or kidney damage)

Severe uncontrolled blood pressure (above 160/100 mmHg)

Persistent painful gynecomastia or rapid breast tissue growth

Severe headaches or visual disturbances

Chest pain, shortness of breath, or signs of cardiovascular distress

Contraindications

Pre-existing liver disease or impaired hepatic function

Active or history of hormone-sensitive cancers (prostate, breast)

Uncontrolled hypertension or significant cardiovascular disease

Elevated hematocrit (above 54%) at baseline

Concurrent use of other hepatotoxic oral steroids (do not stack C17-aa orals)

Pregnancy or potential exposure to pregnant women

Heavy alcohol use (compounded hepatotoxicity risk)

Cholestatic liver conditions or history of drug-induced liver injury

Quality Checklist

Good Signs

Tablets or capsules with consistent size, shape, and color within the same batch

Properly sealed packaging with batch number and expiration date

Third-party lab testing confirming identity and dose accuracy

Purchased from a verified and reputable source with testing history

Dose matches label claim within reasonable tolerance (90-110%)

Warning Signs

Tablets with inconsistent sizing, crumbling, or color variation within the same batch

No third-party testing or certificate of analysis available

Unusually low pricing that suggests underdosed or counterfeit product

Source with no verifiable reputation or testing track record

Bad Signs

Product with no labeling, lot number, or expiration date

Tablets that dissolve or crumble before ingestion, suggesting poor manufacturing

Lab testing showing significant underdosing or presence of unidentified compounds

Product causing unusual or unexpected side effects inconsistent with methandrostenolone

Any signs of contamination, foreign material, or unusual odor

Frequently Asked Questions

Why does Dianabol cause so much water retention if I'm using an aromatase inhibitor?

Water retention from Dianabol has two sources, and an AI only addresses one. First, Dianabol aromatizes to methylestradiol, which the AI suppresses -- this accounts for a portion of the water retention. Second, Dianabol dramatically increases intracellular water and glycogen storage in muscle tissue independent of estrogen. This glycogenolysis-mediated water is not controlled by estrogen and cannot be eliminated with an AI. This is why even with adequate AI dosing, Dianabol users experience obvious bloating and fullness. Most experienced users accept this water retention as a given when running Dbol, knowing that 5-10 lbs will shed within 1-2 weeks of discontinuation as the intracellular water clears.

How much of my Dianabol weight gain is actual muscle vs water?

During a typical 4-6 week Dianabol kickstart yielding 10-20 lbs of weight gain, approximately 5-10 lbs is retained as actual lean tissue, with the remainder being water and glycogen. The water loss is rapid (1-2 weeks post-discontinuation) and dramatic, which can be psychologically deflating. However, strength gains during Dianabol are very real and mostly permanent if the injectable testosterone base continues and training/nutrition remain consistent. The key is to focus on strength progression during the Dbol phase rather than getting too attached to the scale weight, since much of the scale gain is water that will disappear.

Can I stack Dianabol with other oral steroids?

No. Stacking two or more 17-alpha-alkylated oral steroids is a serious mistake that dramatically amplifies hepatotoxicity. Both Dianabol and any other C17-aa oral (such as Anadrol or Halotestin) undergo the same hepatic metabolism and will cause compounded liver damage. Running Dianabol at 30-50 mg/day already elevates liver enzymes significantly within 4-6 weeks. Adding another oral steroid on top would approach dangerous hepatotoxicity levels within weeks. Stick to one 17-alpha-alkylated oral per cycle, with injectables as your secondary compounds.

Why do my lower back and traps cramp so painfully during heavy exercises on Dianabol?

Dianabol causes pronounced lower back pumps (severe cramping in the lower back during deadlifts, rows, and posterior chain work) due to rapid intramuscular water and glycogen accumulation in these heavily activated muscles. This effect is not dangerous but can be debilitating and limit your ability to train those areas hard. Management strategies include: (1) reducing volume on back exercises rather than intensity, (2) stretching aggressively before and after training, (3) staying hydrated, (4) using taurine supplementation (3-5g daily) which helps with muscle cramping, and (5) accepting that some back exercises may need to be reduced during a Dbol kickstart. The pumps resolve completely within days of stopping the compound.

References

Historical review covering the development of synthetic anabolic-androgenic steroids including methandrostenolone (Dianabol), documenting its creation for the US Olympic weightlifting team and subsequent approval and withdrawal from pharmaceutical markets.

Comprehensive review of cardiovascular effects of anabolic-androgenic steroids including oral 17-alpha-alkylated compounds. Documents adverse effects on lipid profiles, blood pressure, left ventricular hypertrophy, and thrombotic events associated with AAS use.

Review of hepatotoxicity mechanisms specific to 17-alpha-alkylated oral anabolic steroids. Documents cholestatic liver injury, peliosis hepatis, and hepatocellular carcinoma risk associated with prolonged use of oral steroids including methandrostenolone.

Case report and literature review documenting the association between long-term anabolic steroid use and hepatic and renal malignancies, reinforcing the importance of limiting oral steroid cycle duration and monitoring liver function.

Comprehensive review of the adverse effects of anabolic-androgenic steroids, including detailed analysis of hepatotoxicity, cardiovascular effects, endocrine disruption, and psychological effects. Provides dose-response and duration-dependent risk assessments for oral and injectable AAS.

Related Peptides

A testosterone base is considered mandatory when running Dianabol. Dianabol suppresses endogenous testosterone production, and without exogenous testosterone, users will experience low-T symptoms including lethargy, sexual dysfunction, and muscle loss. Typical stack is 300-500 mg/week of testosterone enanthate or cypionate with 20-50 mg/day of Dianabol for the first 4-6 weeks.

Dianabol aromatizes heavily to methylestradiol, a potent estrogen that drives water retention, blood pressure elevation, and gynecomastia risk. An aromatase inhibitor is typically necessary at moderate to high Dianabol doses. Anastrozole 0.5 mg every other day is a common starting point, adjusted based on bloodwork and symptom presentation.

Disclaimer

This information is for educational and research purposes only. Consult a healthcare professional before use.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

comparison

BPC-157 vs TB-500: Mechanisms, Dosing & the Wolverine Stack

How BPC-157 and TB-500 compare for healing: mechanism differences, dosing protocols, clinical evidence, and when to combine both in the Wolverine Stack.

Source: peptide-db.com
comparison

What's the dose range for cognitive enhancement versus being too much?

The cognitive 'sweet spot' is 0.5-2 mg/kg body weight (roughly 35-140 mg for a 70 kg person). Doses above 2 mg/kg often shift from antioxidant to pro-oxidant effects, becoming counterproduc…

Source: peptide-db.com
comparison

What's the ideal 5/5 vs 10/3 ratio for Tesa/IPA and when to use each?

5/5 (equal parts) provides balanced GH stimulation suitable for general recovery. The 10/3 (higher tesamorelin) variant emphasizes visceral fat loss and metabolic effects. Choose 5/5 for at…

Source: peptide-db.com
Research context

Read sources and limitations before applying a claim.

Research Indications

Nandrolone (Deca-Durabolin and NPP) elevates prolactin through progestogenic activity. Pramipexole can be used as an alternative to cabergoline for managing prolactin-related side effects including sexual dysfunction and progesterone-mediated gynecomastia, though it is less potent and requires daily dosing. Trenbolone's strong progestogenic activity can elevate prolactin substantially. Pramipexole provides a functional alternative for prolactin control during trenbolone cycles, though users with significant prolactin elevation may find cabergoline more reliable. FDA-approved for the treatment of signs and symptoms of idiopathic Parkinson's disease, both as monotherapy and as adjunct to levodopa. Pramipexole is effective at all stages of the disease and is particularly useful for managing motor symptoms in early Parkinson's. FDA-approved for the treatment of moderate-to-severe primary restless legs syndrome. Low doses taken before bedtime significantly reduce RLS symptoms and improve sleep quality.

Source: peptide-db.com ↗

Research Indications

Irreversibly inactivates aromatase to reduce estradiol levels during testosterone or aromatizable anabolic steroid cycles. The absence of estrogen rebound makes exemestane particularly useful when discontinuing AI support, such as transitioning into PCT. Manages estrogen-mediated fluid retention and subcutaneous bloating common with testosterone and other aromatizable compounds. The mild androgenic activity of exemestane may complement the drier appearance. Titrated to keep estradiol within a healthy range during hormone replacement or enhancement protocols. Because inhibition is irreversible, overshooting the dose requires waiting for new aromatase synthesis rather than simply skipping doses. Bloodwork is essential. FDA-approved for the treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy, and as adjuvant therapy after 2-3 years of tamoxifen. The IES trial demonstrated improved disease-free survival when switching to exemestane after initial tamoxifen treatment. Used off-label alongside TRT to manage estradiol elevations. The irreversible mechanism and mild androgenic properties make it an alternative to anastrozole for men who experience excessive joint pain or mood disturbance on nonsteroidal AIs. Exemestane's irreversible mechanism prevents the estrogen rebound that can occur when stopping a reversible AI like anastrozole at the end of a cycle. This makes it well-suited for managing estrogen during the transition into post-cycle therapy with SERMs.

Source: peptide-db.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Dosing Protocols

Sublingual administration is the preferred route among experienced users due to faster absorption and higher bioavailability compared to oral ingestion. The compound is placed under the tongue as a powder or dissolved in a small amount of liquid and held for 1-2 minutes before swallowing. This bypasses first-pass hepatic metabolism and allows more of the parent compound to reach systemic circulation before conversion to cycloprolylglycine. Standard Nootropic Protocol 10 mg Twice daily (morning and early afternoon) Sublingual Higher Dose Protocol 15 mg

Source: peptide-db.com ↗
Side effects

Common Side Effects

Liver stress and enzyme elevation (ALT, AST) due to 17-alpha alkylated steroidal structure Testosterone suppression (dose- and duration-dependent, expected in all users) Joint dryness and discomfort (related to reduced estrogenic activity and potential drying effect) Hair shedding (consistent with androgenic activity from the DHT-derived structure; may or may not be reversible) Lipid disruption (HDL suppression, LDL elevation) Reduced libido and mood changes secondary to hormonal suppression Mild headaches, particularly during the first week

Source: peptide-db.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →